Michael Makris: Romiplostim Use Allows More Chemotherapy to Be Delivered on Time
Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared a post on LinkedIn about a recent article by Hanny Al-Samkari et al, published in The New England Journal of Medicine:
“Romiplostim use allows more chemotherapy to be delivered on time.
A paper in this week’s New England Journal of Medicine by Hanny Al-Samkari and colleagues reports on a double-blind study of Romiplostim vs Placebo for Chemotherapy-induced Thrombocytopenia.
84% of the Romiplostim and 36% of the Placebo group had no chemotherapy dose modifications.
All the patients had solid tumours.
We do not know if administering more chemo results in a survival advantage, since this would have required a larger trial and much longer follow-up.”
Title: Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
Authors: Hanny Al‑Samkari, César Muñoz, Çağlayan Geredeli, Ippokratis Korantzis, Beatriz González Astorga, Cagatay Arslan, Johnny Francisco Cordeiro Camargo, Florian Scotté, Giuliano Borges, Kejia Wang, Melissa Eisen, David J. Kuter, Gerald A. Soff
Read the Full Article on The New England Journal of Medicine
Other articles featuring Michael Makris on Hemostasis Today.
-
Apr 27, 2026, 13:12Mohamed Isam Sharif: Happy to Have Abstract Presentation at the University of Toronto Hematology Academic Day
-
Apr 27, 2026, 13:10Elvira Grandone: Sex Differences Matter in the Management of Cancer-Associated Thrombosis
-
Apr 27, 2026, 13:07Vadim Nobel: Assessing AI Performance in Real-World Clinical Tasks
-
Apr 27, 2026, 12:57Nuuman M. Kinyasi: Tanzania’s Voice at WFH Congress 2026 – One Nation, One Global Family
-
Apr 27, 2026, 12:50Michelle Leona Cecil: The Mentors Shape What Metrics Can’t Measure in the Bleeding Disorders Community
-
Apr 27, 2026, 12:42Advocacy Efforts for the Bleeding Disorders Community – Bleeding Disorders Council of California
-
Apr 27, 2026, 11:21Clinical Realities of Cancer-Associated Thrombosis on the ISTH Pulse Podcast
-
Apr 27, 2026, 07:08Jeff Schaffnit: Global Voices in Hemophilia Care at the World Federation of Hemophilia World Congress
-
Apr 27, 2026, 06:44Andrew M. Evens: Award-Winning Research from the British Society for Haematology 66th Annual Meeting